111 related articles for article (PubMed ID: 22681911)
1. Angiostatic role of the selective cyclooxygenase-2 inhibitor etoricoxib (MK0663) in experimental lung cancer.
Nadda N; Vaish V; Setia S; Sanyal SN
Biomed Pharmacother; 2012 Sep; 66(6):474-83. PubMed ID: 22681911
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive effects of NSAIDs as inhibitors of cyclooxygenase-2 and inducers of apoptosis in experimental lung carcinogenesis.
Setia S; Vaish V; Sanyal SN
Mol Cell Biochem; 2012 Jul; 366(1-2):89-99. PubMed ID: 22411738
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of intrinsic apoptotic pathway in NSAIDs mediated chemoprevention of experimental lung carcinogenesis.
Setia S; Sanyal SN
Pharmacol Rep; 2012; 64(3):615-24. PubMed ID: 22814015
[TBL] [Abstract][Full Text] [Related]
4. Role of cytokines in experimentally induced lung cancer and chemoprevention by COX-2 selective inhibitor, etoricoxib.
Nadda N; Setia S; Vaish V; Sanyal SN
Mol Cell Biochem; 2013 Jan; 372(1-2):101-12. PubMed ID: 22991065
[TBL] [Abstract][Full Text] [Related]
5. Effect of etoricoxib, a cyclooxygenase-2 selective inhibitor on aberrant crypt formation and apoptosis in 1,2 dimethyl hydrazine induced colon carcinogenesis in rat model.
Sharma P; Kaur J; Sanyal SN
Nutr Hosp; 2010; 25(1):39-48. PubMed ID: 20204254
[TBL] [Abstract][Full Text] [Related]
6. Induction of pulmonary carcinogenesis in Wistar rats by a single dose of 9, 10 dimethylbenz(a)anthracene (DMBA) and the chemopreventive role of diclofenac.
Thakur P; Sanyal SN
Exp Mol Pathol; 2010 Jun; 88(3):394-400. PubMed ID: 20233591
[TBL] [Abstract][Full Text] [Related]
7. The cyclooxygenase-2 inhibitor etoricoxib is a potent chemopreventive agent of colon carcinogenesis in the rat model.
Saini MK; Sharma P; Kaur J; Sanyal SN
J Environ Pathol Toxicol Oncol; 2009; 28(1):39-46. PubMed ID: 19392653
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of Colon Cancer through Inhibition of Angiogenesis and Induction of Apoptosis by Nonsteroidal Anti-Inflammatory Drugs.
Ghanghas P; Jain S; Rana C; Sanyal SN
J Environ Pathol Toxicol Oncol; 2016; 35(3):273-289. PubMed ID: 27910782
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of NF-κB and PCNA in the regulatory pathways of apoptosis by cyclooxygenase-2 inhibitors in experimental lung cancer.
Setia S; Sanyal SN
Mol Cell Biochem; 2012 Oct; 369(1-2):75-86. PubMed ID: 22752388
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of 1,2-dimethylhydrazine-induced colon carcinogenesis by a non-steroidal anti-inflammatory drug, etoricoxib, in rats: inhibition of nuclear factor kappaB.
Tanwar L; Vaish V; Sanyal SN
Asian Pac J Cancer Prev; 2009; 10(6):1141-6. PubMed ID: 20192600
[TBL] [Abstract][Full Text] [Related]
11. Targeting angiogenic pathway for chemoprevention of experimental colon cancer using C-phycocyanin as cyclooxygenase-2 inhibitor.
Saini MK; Sanyal SN
Biochem Cell Biol; 2014 Jun; 92(3):206-18. PubMed ID: 24861078
[TBL] [Abstract][Full Text] [Related]
12. Anti-proliferative and apoptotic effects of etoricoxib, a selective COX-2 inhibitor, on 1,2-dimethylhydrazine dihydrochloride-induced colon carcinogenesis.
Tanwar L; Piplani H; Sanyal S
Asian Pac J Cancer Prev; 2010; 11(5):1329-33. PubMed ID: 21198287
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor kappa B: a pro-inflammatory, transcription factor-mediated signalling pathway in lung carcinogenesis and its inhibition by nonsteroidal anti-inflammatory drugs.
Setia S; Sanyal SN
J Environ Pathol Toxicol Oncol; 2012; 31(1):27-37. PubMed ID: 22591282
[TBL] [Abstract][Full Text] [Related]
14. Chemopreventive action of Imatinib, a tyrosine kinase inhibitor in the regulation of angiogenesis and apoptosis in rat model of lung cancer.
Kumar K; Ghanghas P; Sanyal SN
Mol Cell Biochem; 2018 Oct; 447(1-2):47-61. PubMed ID: 29453608
[TBL] [Abstract][Full Text] [Related]
15. The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment.
Lima-Rodrigues M; Lamas N; Valle-Fernandes A; Cruz A; Vieira A; Oliveira P; Pedrosa J; Castro AG; Reis RM; Baltazar F; Almeida A
Inflamm Res; 2010 Sep; 59(9):743-53. PubMed ID: 20349107
[TBL] [Abstract][Full Text] [Related]
16. Chemopreventive effect of nonsteroidal anti-inflammatory drugs on 9,10-dimethylbenz[a]anthracene-induced lung carcinogenesis in mice.
Saini RK; Sanyal SN
Oncol Res; 2009; 17(11-12):505-18. PubMed ID: 19806781
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of chemopreventive response of two cycloxygenase-2 inhibitors, etoricoxib and diclofenac in rat colon cancer using FTIR and NMR spectroscopic techniques.
Kaur Saini M; Nath Sanyal S
Nutr Hosp; 2010; 25(4):577-85. PubMed ID: 20694294
[TBL] [Abstract][Full Text] [Related]
18. Chemopreventive action of diclofenac in dimethybenzanthracene induced lung cancer in female Wistar rat.
Thakur P; Sanyal SN
J Environ Pathol Toxicol Oncol; 2010; 29(3):255-65. PubMed ID: 21303331
[TBL] [Abstract][Full Text] [Related]
19. Pain management after elective hallux valgus surgery: a prospective randomized double-blind study comparing etoricoxib and tramadol.
Brattwall M; Turan I; Jakobsson J
Anesth Analg; 2010 Aug; 111(2):544-9. PubMed ID: 20584877
[TBL] [Abstract][Full Text] [Related]
20. Benefits of the antioxidant and anti-inflammatory activity of etoricoxib in the prevention of ovarian ischemia/reperfusion injury induced experimentally in rats.
Yapca OE; Turan MI; Yilmaz I; Salman S; Gulapoglu M; Suleyman H
J Obstet Gynaecol Res; 2014 Jun; 40(6):1674-9. PubMed ID: 24888933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
